142 related articles for article (PubMed ID: 9168061)
1. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
[TBL] [Abstract][Full Text] [Related]
2. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity.
Nair AP; Hirsch HH; Moroni C
Oncogene; 1992 Oct; 7(10):1963-72. PubMed ID: 1408138
[TBL] [Abstract][Full Text] [Related]
3. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
Imber R; Fabbro D
Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
[TBL] [Abstract][Full Text] [Related]
4. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
Stoecklin G; Gross B; Ming XF; Moroni C
Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
[TBL] [Abstract][Full Text] [Related]
6. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
Chen SC; Redenius D; Young JC; Schwartz RC
Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
[TBL] [Abstract][Full Text] [Related]
7. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene.
Hirsch HH; Nair AP; Moroni C
J Exp Med; 1993 Aug; 178(2):403-11. PubMed ID: 8340751
[TBL] [Abstract][Full Text] [Related]
8. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
[TBL] [Abstract][Full Text] [Related]
9. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
Thomassen DG; Gilmer TM; Annab LA; Barrett JC
Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
[TBL] [Abstract][Full Text] [Related]
10. Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6.
Buess M; Engler O; Hirsch HH; Moroni C
Oncogene; 1999 Feb; 18(7):1487-94. PubMed ID: 10050885
[TBL] [Abstract][Full Text] [Related]
11. Global analysis of differential gene expression after transformation with the v-H-ras oncogene in a murine tumor model.
Brem R; Certa U; Neeb M; Nair AP; Moroni C
Oncogene; 2001 May; 20(22):2854-8. PubMed ID: 11420697
[TBL] [Abstract][Full Text] [Related]
12. Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cells.
Duménil D; Neel H; Lacout C; Dautry F
Exp Hematol; 1994 Feb; 22(2):178-85. PubMed ID: 8299738
[TBL] [Abstract][Full Text] [Related]
13. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
14. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.
Diamantis ID; Nair AP; Hirsch HH; Moroni C
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9299-302. PubMed ID: 2512578
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of dominant and recessive IL-3-independent hematopoietic transformants.
Kiser KF; Colombi M; Moroni C
Oncogene; 2006 Oct; 25(50):6595-603. PubMed ID: 16702946
[TBL] [Abstract][Full Text] [Related]
17. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
18. Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
Beaupre DM; Talpaz M; Marini FC; Cristiano RJ; Roth JA; Estrov Z; Albitar M; Freedman MH; Kurzrock R
Cancer Res; 1999 Jun; 59(12):2971-80. PubMed ID: 10383163
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA.
Nair AP; Hahn S; Banholzer R; Hirsch HH; Moroni C
Nature; 1994 May; 369(6477):239-42. PubMed ID: 8183344
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms.
McCubrey J; Holland G; McKearn J; Risser R
Oncogene Res; 1989; 4(2):97-109. PubMed ID: 2785667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
